June 2007 Oncology News International

Publication
Article

Focus on Hematology

Meta-Analysis Shows Rituximab-Chemo Increases Overall Survival in Indolent/Mantle Cell Lymphoma

Velcade/Doxil Approved for Relapsed or Refractory Multiple Myeloma Pts

Focus on Breast Cancer

Novel PET Tracer Detects Breast Tumors and Mets

Vitamin E-Based Paclitaxel May Be Less Neurotoxic

Removing Stage IV Primary May Cut Mortality

Focus on Lung Cancer

Canfosfamide Boosts Chemotherapy's Benefit in NSCLC

Best Measure of Lung Cancer Screening: Curability or Mortality?

Industry Watch

Enrollment Begins for Phase I Trial of NPI-0052 in Myeloma

PEG-SN38 Shows Anti-Tumor Activity in Resistant Models

Cougar Biotechnology Reports Positive Data on CB7630

Focus on Colon Cancer

Colonoscopy With Polyp Removal Reduces Mortality

Surveillance Colonoscopy Guidelines Not Being Followed

Cancer Care & Economics

Virtual Colonoscopy Gaining New Respect as a Sensitive and Cost-Effective CRC Screening Tool

Medicare Reacts to Recent Scrutiny of ESAs

Value-Based Competition Key to Healthcare Reform

Focus on Oncology Nursing

Gastric Ca Registry IDs Those With CDH1 Mutation

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content